Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
GLP-1R Agonist Exendin-4 Protects Against Hemorrhagic Transformation Induced by rtPA After Ischemic Stroke via the Wnt/beta-Catenin Signaling Pathway
A study found that slower gastric emptying was a key factor in the increased satiety and reduced hunger experienced by participants taking GLP-1 agonists
Want to know more
GLP-1 Market Industry Trends and Global Forecasts 2024-2035: Over 150 GLP-1 Drug Candidates in Development for Multiple Indications, Type 2 Diabetes and Obesity Drive GLP-1 Drug Development Boom GLP-1 Drugs GLP-1 Drugs Distribution Dublin, March 18, 2025 (GLOBE NEWSWIRE) -- The "GLP-1 Market Industry Trends and Global Forecasts to 2035, by Type of Molecule, Active Compound Used, Type of GLP-1 Agonist Drugs, Type of Agonist, Route of Administration, Target indication and Key Geographical Regions" report has been added to ResearchAndMarkets.com's offering
US$ 19.99
US$ 28.27
US$ 29.68
US$ 29.10
US$ 26.77
US$ 20.74
US$ 29.93
US$ 26.06
